La Jolla Pharmaceutical Mergers & Acquisitions

La Jolla Pharmaceutical M&A Summary

La Jolla Pharmaceutical has acquired 2 companies of its own, including 1 in the last 5 years.

La Jolla Pharmaceutical’s largest acquisition to date was in 2020, when it acquired Tetraphase Pharmaceuticals for $43M. La Jolla Pharmaceutical has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 1

La Jolla Pharmaceutical

La Jolla Pharmaceutical Co.

201 Jones Road, Suite 400,
Waltham, Massachusetts 02451
United States,
www.lajollapharmaceutical.com

All (2) Buy (2) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-06-24 Tetraphase Pharmaceuticals · Life Science
Watertown, Massachusetts · www.tphase.com

Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multidrug-resistant (MDR) infections. Tetraphase Pharmaceuticals was founded in 2006 and is based in Watertown, Massachusetts.

Advisors: Janney Montgomery Scott , Wilmer Cutler Pickering Hale and Dorr
43 Going Private

La Jolla Pharmaceutical

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.